Steve Wesley

Steve currently leads a National Accounts team for Eagle Pharma in the US focusing on acute treatment for the rare Malignant Hyperthermia, and breaching the Oncology infusion space. Responsibilities for all Acute and Specialty GPO's, Distributors, and US Wholesalers. Prior to Eagle Steve was Snr Director of Global Trade Operations at Horizon and has held several strategic accounts and trade roles at Novartis, The Medicines Company, Cardinal and Convatec.